Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More

Mirus Bio™ TransIT™-Keratinocyte Transfection Reagent

Catalog No. MIR2806 Shop All Mirus Bio LLC Products
Change view
Click to view available options
Quantity:
0.4 mL
1 mL
5 mL
10 mL
4 product options available for selection
Product selection table with 4 available options. Use arrow keys to navigate and Enter or Space to select.
Catalog No. Quantity
MIR2806 10 mL
MIR2804 0.4 mL
MIR2800 1 mL
MIR2805 5 mL
Use arrow keys to navigate between rows. Press Enter or Space to select a product option. 4 options available.
4 options
Catalog No. MIR2806 Supplier Mirus Bio™ Supplier No. MIR 2806
Only null left
Add to Cart
Add to Cart

Includes

TransIT-Keratinocyte transfection reagent, supplied as a ready-to-use solution.

TransIT™-Keratinocyte Transfection Reagent designed for highly efficient, low-toxicity DNA transfection in primary keratinocytes. Transfection does not required medium changes and can be carried out in serum-containing medium.

  • TransIT-Keratinocyte transfection reagent, supplied as a ready-to-use solution.
  • Optimized transfection performance in keratinocyte cells.
  • Low cellular toxicity maintains cell density and reduces experimental bias.
  • Allows 20 to 30% transfection efficiency in keratinocytes.
  • Concentration: 1.37 mg/mL

Specifications

Cell Type Mammalian
Format Tube
Promoter None (Promoterless)
Transfection Technique Chemical Transfection
Concentration 1.37 mg/mL
For Use With (Application) Highly efficient DNA or RNA transfection with minimal cellular toxicity, specifically for primary keratinocytes
Product Type Transfection Reagent
Quantity 10 mL
Sterility Sterile
Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.